<?xml-stylesheet type='text/xsl' href='ctgovTransform.xsl'?>
<CT.GOV_Trial requestNumber="708">
  <stage>Registered</stage>
  <submitdate>7/09/2005</submitdate>
  <approvaldate>7/09/2005</approvaldate>
  <nctid>NCT00155987</nctid>
  <trial_identification>
    <studytitle>The DECRA Trial: Early Decompressive Craniectomy in Patients With Severe Traumatic Brain Injury</studytitle>
    <scientifictitle>Multi-centre Prospective Randomised Trial of Early Decompressive Craniectomy in Patients With Severe Traumatic Brain Injury</scientifictitle>
    <utrn />
    <trialacronym />
    <secondaryid>68/02</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Brain Injuries</healthcondition>
    <conditioncode>
      <conditioncode1>Skin</conditioncode1>
      <conditioncode2>Other skin conditions</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Injuries and Accidents</conditioncode1>
      <conditioncode2>Other injuries and accidents</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Neurological</conditioncode1>
      <conditioncode2>Other neurological disorders</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Treatment: surgery - Early decompressive craniectomy

Treatment: surgery: Early decompressive craniectomy
Large bifrontotemporal decompressive craniectomy

</interventions>
    <comparator />
    <control />
    <interventioncode>Treatment: surgery</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Proportion (%) of favourable outcomes (GOSE 5-8)</outcome>
      <timepoint>6 month post injury</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Mean and maximum hourly intracranial pressure (ICP)</outcome>
      <timepoint>36hrs post randomisation</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Favourable outcomes (GOSE)</outcome>
      <timepoint>12 months post injury</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Mean GOSE using ordinal logistic regression</outcome>
      <timepoint>6 months and 12 months</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Mortality</outcome>
      <timepoint>hospital, 6 months, 12 months</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>length of stay</outcome>
      <timepoint>ICU admisssion</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Brain metabolites using microdialysis (The Alfred Hospital only)</outcome>
      <timepoint>During monitoring phase</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>-  Age 15 - 60 years and within the first 72 hrs from time of injury

          -  Severe diffuse Traumatic Brain Injury defined as:

          -  GCS &lt; 9 and CT scan* with any evidence of brain swelling CT brain scan (DII + some
             evidence of swelling or DIII or DIV) OR

          -  GCS &gt;8 before intubation and DIII or DIV CT brain scan (basal cistern compression Â±
             midline shift)

          -  ICP monitor in situ. EVD recommended.

          -  "Refractory ICP" despite best conventional management. Refractory ICP in this study
             will be defined as the spontaneous persistent increase in ICP despite optimal
             conventional ICU therapies (including intermittent EVD venting) of &gt;20mm Hg for more
             than 15 mins (continuously or cumulative over one hour).</inclusivecriteria>
    <inclusiveminage>15</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>60</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>Exclusion criteria:

          -  Intracranial haemorrhage &gt; 3 cm diameter

          -  Intracranial mixed haemorrhagic contusion &gt;5cm in long axis

          -  Previous craniectomy

          -  EDH/SDH/ or large contusion requiring evacuation

          -  EDH/SDH &gt;0.5 cm thickness

          -  Spinal cord injury

          -  Penetrating brain injury

          -  Arrest at scene

          -  Unreactive pupils &gt;4mm, and GCS=3

          -  Neurosurgery contraindicated (eg: severe coagulopathy)

          -  No chance of survival after consideration of CT and clinical findings following
             Neurosurgical consultant assessment (eg hemispheric infarct after carotid dissection).</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment />
    <sequence />
    <masking>Blinded (masking used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures />
    <endpoint />
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3>The people assessing the outcomes</masking3>
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Phase 3</phase>
    <anticipatedstartdate />
    <actualstartdate>1/08/2003</actualstartdate>
    <anticipatedenddate />
    <actualenddate />
    <samplesize>165</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Unknown status</recruitmentstatus>
    <anticipatedlastvisitdate>1/12/2010</anticipatedlastvisitdate>
    <actuallastvisitdate />
    <dataanalysis />
    <withdrawnreason />
    <withdrawnreasonother />
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate>VIC</recruitmentstate>
    <hospital>The Alfred Hospital - Melbourne</hospital>
    <postcode>3004 - Melbourne</postcode>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Other</primarysponsortype>
    <primarysponsorname>National Trauma Research Institute</primarysponsorname>
    <primarysponsoraddress />
    <primarysponsorcountry />
    <othercollaborator>
      <othercollaboratortype>Other</othercollaboratortype>
      <othercollaboratorname>National Health and Medical Research Council, Australia</othercollaboratorname>
      <othercollaboratoraddress />
      <othercollaboratorcountry />
    </othercollaborator>
    <othercollaborator>
      <othercollaboratortype>Other</othercollaboratortype>
      <othercollaboratorname>Victorian Trauma Foundation</othercollaboratorname>
      <othercollaboratoraddress />
      <othercollaboratorcountry />
    </othercollaborator>
    <othercollaborator>
      <othercollaboratortype>Other</othercollaboratortype>
      <othercollaboratorname>ANZICS Foundation</othercollaboratorname>
      <othercollaboratoraddress />
      <othercollaboratorcountry />
    </othercollaborator>
    <othercollaborator>
      <othercollaboratortype>Other</othercollaboratortype>
      <othercollaboratorname>Western Australian Institute for Medical Research</othercollaboratorname>
      <othercollaboratoraddress />
      <othercollaboratorcountry />
    </othercollaborator>
  </sponsorship>
  <ethicsAndSummary>
    <summary>This is a multi-centre randomised trial to evaluate the effect of early decompressive
      craniectomy on neurological function in patients with severe traumatic brain injury.

      The primary outcome is neurological function measured at 6 months post injury using the
      Glasgow Outcome Score. Neurological function is qualified as proportion of favourable
      outcomes (Glasgow Outcome Score Extended [GOSE] grades 5-8).</summary>
    <trialwebsite>https://clinicaltrials.gov/show/NCT00155987</trialwebsite>
    <publication />
    <ethicsreview />
    <publicnotes />
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>D. J. Cooper</name>
      <address>The Alfred Hospital &amp; National Trauma Research Institute</address>
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Public Queries</type>
    </contact>
  </contacts>
</CT.GOV_Trial>